SC
NUVA

Sagefield Capital’s NuVasive, Inc. NUVA Stock Holding History

Sagefield Capital’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,700
Closed -$401K – 100
2023
Q1 		$401K Buy
+9,700
New +$415K 0.09% 85

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Sagefield Capital's NUVA Position: Q2 2023 in Review

Sagefield Capital sold out of NuVasive, Inc. (NUVA) in Q2 2023, closing a stake of 9,700 shares — an estimated $401K sold.

Sagefield Capital first reported a position in NUVA in Q1 2023 and held it in 1 quarter. The position peaked at $401K in Q1 2023. 228 funds tracked by Wall St. Rank hold NUVA as of Q2 2023.

  • Sagefield Capital reported no remaining NuVasive, Inc. position as of Q2 2023 after selling out during the quarter.
  • Sagefield Capital sold 9,700 NuVasive, Inc. shares in Q2 2023, an estimated $401K.
  • Sagefield Capital first reported a position in NuVasive, Inc. in Q1 2023 and held it in 1 quarter.
  • Sagefield Capital's NuVasive, Inc. position peaked at $401K in Q1 2023.
  • 228 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2023.

Based on Sagefield Capital's 13F filing for Q2 2023, filed 14 Aug 2023.